<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04393376</url>
  </required_header>
  <id_info>
    <org_study_id>NL73261.018.20</org_study_id>
    <nct_id>NCT04393376</nct_id>
  </id_info>
  <brief_title>PSA Glycomics Assay for Early Detection of Prostate Cancer</brief_title>
  <official_title>Evaluation of Prostate-Specific Antigen Glycomics Assay for the Early Detection of Prostate Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof.dr. H.P. Beerlage</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Netherlands Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The principal aim of this pilot study is to test whether the PSA Glycomics Assay on urine and
      serum samples can provide insights regarding the disease state of patients with elevated PSA
      concentrations, as well as to accurately identify if the patient has prostate cancer and, in
      the case of prostate cancer, to determine its level of aggressiveness.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PSA Glycomics Assay</measure>
    <time_frame>1 year</time_frame>
    <description>The relative abundance of glycoforms of PSA in plasma and urine from the subjects will be measured. These will be related to the stage of PCa and compared to non-prostate cancer patients.</description>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>PSA</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PSA Glycomics Assay</intervention_name>
    <description>PSA Glycomics Assay will be performed on urine and blood samples</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with elevated PSA (&gt;3 ng/mL)

          -  Signed informed consent

        Exclusion Criteria:

          -  Patients that have a cystitis (bladder infection)

          -  Patients under chemotherapy

          -  Patients using 5-alpha reductase inhibitors

          -  History or presence of cancers, or non-prostate urological disorders.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>J R Oddens, MD, PhD</last_name>
    <phone>+31(0)20-5668637</phone>
    <email>j.r.oddens@amsterdamumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amsterdam UMC, location AMC</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <contact>
      <last_name>J R Oddens, MD, PhD</last_name>
      <phone>+31(0)20-5668637</phone>
      <email>j.r.oddens@amsterdamumc.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 14, 2020</study_first_submitted>
  <study_first_submitted_qc>May 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Prof.dr. H.P. Beerlage</investigator_full_name>
    <investigator_title>Urologist, Head of Department of Urology</investigator_title>
  </responsible_party>
  <keyword>Prostate Cancer</keyword>
  <keyword>PSA</keyword>
  <keyword>Glycomics Assay</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

